M

Meridian Bioscience Inc
LSE:0K0K

Watchlist Manager
Meridian Bioscience Inc
LSE:0K0K
Watchlist
Price: 33.97 USD 0.06% Market Closed
Market Cap: $1.4B

Relative Value

There is not enough data to reliably calculate the relative value of 0K0K.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

0K0K Relative Value
Base Case
Not Available
M
Worst Case
Base Case
Best Case

Multiples Across Competitors

0K0K Competitors Multiples
Meridian Bioscience Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Meridian Bioscience Inc
LSE:0K0K
1.5B USD 4.5 35 15.5 18.9
JP
Hoya Corp
TSE:7741
8.8T JPY 9.9 42.1 26.1 31.3
CH
Alcon AG
SIX:ALC
30.9B CHF 3.9 38.1 19.9 38.7
US
Medline Inc
NASDAQ:MDLN
35.5B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
122.3B DKK 4.4 33.6 15.5 18.4
US
Align Technology Inc
NASDAQ:ALGN
11.7B USD 2.9 30.9 14 17.8
UK
ConvaTec Group PLC
LSE:CTEC
4.7B GBP 2.7 29.4 17.7 28.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.9B CNY 9.4 25.9 23.3 23.3
KR
HLB Inc
KOSDAQ:028300
7.3T KRW 83.6 -30.7 -76.7 -72.6
CA
Bausch + Lomb Corp
NYSE:BLCO
5.9B USD 1.2 -19.4 19.4 91.5
CH
Ypsomed Holding AG
SIX:YPSN
4.2B CHF 5.3 21.7 14.1 19.1
P/E Multiple
Earnings Growth PEG
US
M
Meridian Bioscience Inc
LSE:0K0K
Average P/E: 32.1
35
N/A N/A
JP
Hoya Corp
TSE:7741
42.1
13%
3.2
CH
Alcon AG
SIX:ALC
38.1
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.6
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
30.9
27%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.4
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
25.9
9%
2.9
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -30.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.4 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
21.7
32%
0.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
M
Meridian Bioscience Inc
LSE:0K0K
Average EV/EBITDA: 18.4
15.5
N/A N/A
JP
Hoya Corp
TSE:7741
26.1
11%
2.4
CH
Alcon AG
SIX:ALC
19.9
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.5
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
17.7
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
15%
1.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -76.7 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
19.4
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
14.1
21%
0.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
M
Meridian Bioscience Inc
LSE:0K0K
Average EV/EBIT: 32
18.9
N/A N/A
JP
Hoya Corp
TSE:7741
31.3
N/A N/A
CH
Alcon AG
SIX:ALC
38.7
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.4
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
17.8
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
28.8
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
11%
2.1
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -72.6 N/A N/A
CA
Bausch + Lomb Corp
NYSE:BLCO
91.5
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
19.1
29%
0.7